Louis Chen

Stock Analyst at Cantor Fitzgerald

(n/a)
# 5,005
Out of 5,006 analysts
9
Total ratings
9.09%
Success rate
-57.88%
Average return
Main Sectors:

Stocks Rated by Louis Chen

Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $3.55
Upside: -
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $41.21
Upside: +33.46%